Investing
Here’s a quick recap of some of the most impactful resource sector news items for the week. The period saw three miners rescued after...
Connect with us
Hi, what are you looking for?
Daily Market Solution
- Stock
FCC greenlights Paramount’s $8 billion merger with entertainment group Skydance
Microsoft’s Satya Nadella says job cuts have been ‘weighing heavily’ on him
UnitedHealth says it faces DOJ investigation over Medicare billing practices
Uber will let women drivers and riders request to avoid being paired with men
Alphabet beats earnings expectations, raises spending forecast
- Economy
- Editor’s Pick
Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs
Tucker Carlson says father Trump will give ‘spanking’ at rowdy Georgia rally
A GOP operative accused a monastery of voter fraud. Nuns fought back.
American creating deepfakes targeting Harris works with Russian intel, documents show
Early voting in Wisconsin slowed by label printing problems
- Latest News
Trump’s executive order on birthright citizenship blocked by another federal appeals judge in latest ruling
Michelle Obama portraitist’s exhibit with trans Statue of Liberty pulled after pressure from Vance
House Freedom Caucus conservative to enter race for South Carolina governor
Pelosi confident about Dems’ chances to win House, predicts Jeffries will be speaker
Pentagon freezes out DC think tanks in new move, citing ‘America last’ concerns
Investing
Here’s a quick recap of some of the most impactful resource sector news items for the week. The period saw three miners rescued after...
Investing
Here’s a quick recap of some of the most impactful resource sector news items for the week. The period saw three miners rescued after...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...
Investing
Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has received firm commitments to...